# Study to Investigate the Absorption, Metabolism and Excretion of [14C] AC0010 in Patients With Advanced NSCLC

> **NCT03001609** · PHASE1 · COMPLETED · sponsor: **Hangzhou ACEA Pharmaceutical Research Co., Ltd.** · enrollment: 7 (actual)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DRUG:** AC0010

## Key facts

- **NCT ID:** NCT03001609
- **Lead sponsor:** Hangzhou ACEA Pharmaceutical Research Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2017-08
- **Final completion:** 2017-09
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2017-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03001609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03001609, "Study to Investigate the Absorption, Metabolism and Excretion of [14C] AC0010 in Patients With Advanced NSCLC". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03001609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*